RELMADA THERAPEUTICS, INC. Gain (Loss) on Extinguishment of Debt
RELMADA THERAPEUTICS, INC. (RLMD) reported Gain (Loss) on Extinguishment of Debt of $6.35 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2023-08-08
- RELMADA THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2019-06-30 was $0.00.
- RELMADA THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2019-03-31 was $0.00.
- RELMADA THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2018-12-31 was -$3.77M.
- RELMADA THERAPEUTICS, INC. gain (loss) on extinguishment of debt for fiscal 2022 was $6.35M.
- RELMADA THERAPEUTICS, INC. gain (loss) on extinguishment of debt for fiscal 2019 was -$3.77M.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $6.35M 10-K · filed 2023-03-23 | |||
| 2022-06-30 | $6.35M 10-Q · filed 2023-08-08 | |||
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $0.00 derived: sum of 2 quarters · filed 2021-03-24 | -$3.77M derived: sum of 3 quarters · filed 2021-03-24 | -$3.77M 10-K · filed 2021-03-24 |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-KT 6 month · filed 2019-05-15 | -$3.77M derived: sum of 2 quarters · filed 2019-05-15 | -$3.77M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$3.77M 10-Q · filed 2019-02-13 | -$3.77M 10-KT · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |